AbbVie Patient Access Support includes programs that provide access and financial support and treatment-related resources to patients. We can help identify financial assistance options to support patients in accessing prescribed AbbVie medications, including eligibility for myAbbVie Assist.
myAbbVie Assist provides free medicine to qualifying patients. If you are uninsured or have limited insurance coverage, you may be eligible to receive prescribed AbbVie medication at no cost from our Program. Patients with commercial insurance plans requiring them to apply to myAbbVie Assist as a condition of, requirement for, or prerequisite to coverage of relevant AbbVie products commonly known as alternate funding programs, are not eligible for myAbbVie Assist.
Is the online application right for you?
Our online application is for use by people over the age of eighteen and seeking assistance (the patient) for either HUMIRA® (adalimumab), SKYRIZI® (risankizumab-rzaa) RINVOQ®(upadacitinib) or MAVYRET® (glecaprevir/pibrentasvir). We will ask you to register and complete an application. Before you start, please make sure that you have electronic copies of the necessary documents, listed further below.
While you can apply online, we will also need the health care provider who has prescribed your medication to submit application documents separately. Once you have submitted your application and supporting documents, we will contact your health care provider to obtain your prescription and other needed information.
This website will guide you through the steps needed to complete your application and will allow you to sign up for text or e-mail updates from the program:
Step One: Enter your information into our website and create an account.
Step Two: Follow the screens to provide income and insurance information for the application process. Please note: We will assess income electronically when you provide written instructions to the Program under the Fair Credit Reporting Act, solely to determine patient assistance program eligibility. If the program is unable to determine income, you may be asked to provide additional financial documentation such as your most recent tax return or similar document.
The system will prompt you to upload copies of your insurance cards if you have them.
Step Three: Upload any additional documents that may help us understand your difficulty accessing your medicine.
Step Four: Review our privacy notice and program terms to understand how we use your personal data, acknowledge you understanding and submit.
We will contact your prescribing doctor for the remaining information. We also will notify you and your health care provider after we have reviewed your application. If you are approved for assistance through the myAbbVie Assist Patient Assistance Program, you may use this site to schedule refill deliveries based on the prescription from your health care provider.
What documents must be electronically available?
Click here for an optional expense form that can be used to document your prescription and medical expenses.
What if I am not the patient OR I do not have all of my documents available electronically?
Step One: Please download and print the application to submit by mail or fax: HUMIRA | SKYRIZI | RINVOQ | MAVYRET
Step Two: Follow the instructions on the first page to complete the application.
Step Three: Obtain the patient’s signature and date in all needed sections.
Step Four: Gather copies of the supporting documentation to include with the application.
Step Five: Take the application to your health care provider. He or she should complete the HEALTH CARE PROVIDER page to include signing and dating the form at the bottom.
Step Six: Please fax or mail the completed application and copies of your documents to us. Note that you and your health care provider can send to us separately.
AbbVie Patient Access Support
D-617927, AP5 NE 1 N. Waukegan Rd.
North Chicago, IL 60064
If you need help at any point during this process, please call us at 1-800-222-6885 Monday through Friday 7:00 AM to 7:00 PM Central Time.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?